<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1213"/><api:result><api:object category="publication" id="1213" last-affected-when="2024-03-18T00:22:54.62+00:00" last-modified-when="2024-03-18T00:22:54.62+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1213" created-when="2010-05-17T13:47:33.67+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-08-08</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="4211972" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="115373" last-modified-when="2022-12-29T04:42:12.403+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Hypoxia in solid tumours has been correlated with poor prognosis and resistance to radiation and chemotherapy. Hypoxia is also a strong stimulus for gene expression. We previously proposed a gene therapy approach which exploits the presence of severe hypoxia in tumours for the induction of therapeutic genes. Hypoxic cells are known to have a reduced metabolic rate, transcription and translation. These facts may prevent gene transfer and therefore warranted further investigation. In this paper the feasibility of gene delivery in vitro under tumour conditions was demonstrated. DNA was delivered in vitro using a peptide-mediated non-viral system. Across a range of oxygen tensions and mammalian cell lines (including human tumour and endothelial cells) it was shown that hypoxic cells could be transfected. Transfection efficiencies varied depending on the level of hypoxia, cell characteristics and gene promoters used. An in vitro model of hypoxia/reoxygenation, designed to mimic the variable nature of tumour hypoxia, showed that hypoxic preconditioning and reoxygenation alone did not reduce transfection efficiency significantly; only chronic anoxia reduced transfection. The fact that neither intermediate hypoxia nor intermittent anoxia significantly reduced transfection is promising for future hypoxia-targeted gene therapy strategies.

</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer </api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>green fluorescent protein</api:keyword><api:keyword>tumour conditions</api:keyword><api:keyword>anoxia</api:keyword><api:keyword>BLADDER-CARCINOMA</api:keyword><api:keyword>SOLID TUMORS</api:keyword><api:keyword>LINE</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>PROTEINS</api:keyword><api:keyword>OXYGENATION</api:keyword><api:keyword>METASTASES</api:keyword><api:keyword>CANCERS</api:keyword><api:keyword>FLUX</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text> Â© 2000 Cancer Research Campaign. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="public-url" type="text" display-name="Public URL"><api:text>https://eprints.whiterose.ac.uk/id/eprint/115373</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Cancer Research UK</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>https://doi.org/%2010.1054/bjoc.2000.1318</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>21</api:day><api:month>4</api:month><api:year>2017</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>2017</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Public</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/1692725"><api:filename>Gene delivery to hypoxic cells in vitro.pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/115373/1/Gene delivery to hypoxic cells in vitro.pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>159364</api:file-size><api:mime-type>application/pdf</api:mime-type><api:checksum algorithm="md5">74C2CC8F7D9776408F1E1C513A5EB8B6</api:checksum><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2319668" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1054/bjoc.2000.1318" last-modified-when="2023-06-03T08:03:08.137+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1054/bjoc.2000.1318</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>23</api:day><api:month>5</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field></api:native></api:record><api:record format="native" id="95651" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033869074" last-modified-when="2023-12-06T01:58:46.723+00:00"><api:citation-count>22</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Hypoxia in solid tumours has been correlated with poor prognosis and resistance to radiation and chemotherapy. Hypoxia is also a strong stimulus for gene expression. We previously proposed a gene therapy approach which exploits the presence of severe hypoxia in tumours for the induction of therapeutic genes. Hypoxic cells are known to have a reduced metabolic rate, transcription and translation. These facts may prevent gene transfer and therefore warranted further investigation. In this paper the feasibility of gene delivery in vitro under tumour conditions was demonstrated. DNA was delivered in vitro using a peptide-mediated non-viral system. Across a range of oxygen tensions and mammalian cell lines (including human tumour and endothelial cells) it was shown that hypoxic cells could be transfected. Transfection efficiencies varied depending on the level of hypoxia, cell characteristics and gene promoters used. An in vitro model of hypoxia/reoxygenation, designed to mimic the variable nature of tumour hypoxia, showed that hypoxic preconditioning and reoxygenation alone did not reduce transfection efficiency significantly; only chronic anoxia reduced transfection. The fact that neither intermediate hypoxia nor intermittent anoxia significantly reduced transfection is promising for future hypoxia-targeted gene therapy strategies. (C) 2000 Cancer Research Campaign.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Mount Vernon Hospital</api:line><api:line type="city">Northwood</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701404593</api:identifier></api:identifiers></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Mount Vernon Hospital</api:line><api:line type="city">Northwood</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6507757639</api:identifier></api:identifiers></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="scopus-author-id">7202601084</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Mount Vernon Hospital</api:line><api:line type="city">Northwood</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005831992</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10944609</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field></api:native></api:record><api:record format="native" id="1213" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10944609" last-modified-when="2020-04-29T01:07:11.87+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Hypoxia in solid tumours has been correlated with poor prognosis and resistance to radiation and chemotherapy. Hypoxia is also a strong stimulus for gene expression. We previously proposed a gene therapy approach which exploits the presence of severe hypoxia in tumours for the induction of therapeutic genes. Hypoxic cells are known to have a reduced metabolic rate, transcription and translation. These facts may prevent gene transfer and therefore warranted further investigation. In this paper the feasibility of gene delivery in vitro under tumour conditions was demonstrated. DNA was delivered in vitro using a peptide-mediated non-viral system. Across a range of oxygen tensions and mammalian cell lines (including human tumour and endothelial cells) it was shown that hypoxic cells could be transfected. Transfection efficiencies varied depending on the level of hypoxia, cell characteristics and gene promoters used. An in vitro model of hypoxia/reoxygenation, designed to mimic the variable nature of tumour hypoxia, showed that hypoxic preconditioning and reoxygenation alone did not reduce transfection efficiency significantly; only chronic anoxia reduced transfection. The fact that neither intermediate hypoxia nor intermittent anoxia significantly reduced transfection is promising for future hypoxia-targeted gene therapy strategies.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Tumour Microcirculation Group, Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, HA6 2JR, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10944609</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2363510</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Cell Line</api:keyword><api:keyword scheme="mesh">Cell Separation</api:keyword><api:keyword scheme="mesh">Feasibility Studies</api:keyword><api:keyword scheme="mesh">Flow Cytometry</api:keyword><api:keyword scheme="mesh">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh">Genetic Therapy</api:keyword><api:keyword scheme="mesh">Genetic Vectors</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypoxia</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Oxygen</api:keyword><api:keyword scheme="mesh">Peptides</api:keyword><api:keyword scheme="mesh">Phosphatidylethanolamines</api:keyword><api:keyword scheme="mesh">Plasmids</api:keyword><api:keyword scheme="mesh">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh">Time Factors</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0007092000913181</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>15</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field></api:native></api:record><api:record format="native" id="882320" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10944609" last-modified-when="2024-01-30T19:38:54.89+00:00"><api:citation-count>9</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Hypoxia in solid tumours has been correlated with poor prognosis and resistance to radiation and chemotherapy. Hypoxia is also a strong stimulus for gene expression. We previously proposed a gene therapy approach which exploits the presence of severe hypoxia in tumours for the induction of therapeutic genes. Hypoxic cells are known to have a reduced metabolic rate, transcription and translation. These facts may prevent gene transfer and therefore warranted further investigation. In this paper the feasibility of gene delivery in vitro under tumour conditions was demonstrated. DNA was delivered in vitro using a peptide-mediated non-viral system. Across a range of oxygen tensions and mammalian cell lines (including human tumour and endothelial cells) it was shown that hypoxic cells could be transfected. Transfection efficiencies varied depending on the level of hypoxia, cell characteristics and gene promoters used. An in vitro model of hypoxia/reoxygenation, designed to mimic the variable nature of tumour hypoxia, showed that hypoxic preconditioning and reoxygenation alone did not reduce transfection efficiency significantly; only chronic anoxia reduced transfection. The fact that neither intermediate hypoxia nor intermittent anoxia significantly reduced transfection is promising for future hypoxia-targeted gene therapy strategies.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Tumour Microcirculation Group, Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, HA6 2JR, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-8254-376X</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10944609</api:identifier><api:identifier scheme="pmc">PMC2363510</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cell Line</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Oxygen</api:keyword><api:keyword scheme="mesh">Phosphatidylethanolamines</api:keyword><api:keyword scheme="mesh">Peptides</api:keyword><api:keyword scheme="mesh">Flow Cytometry</api:keyword><api:keyword scheme="mesh">Cell Separation</api:keyword><api:keyword scheme="mesh">Feasibility Studies</api:keyword><api:keyword scheme="mesh">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Genetic Vectors</api:keyword><api:keyword scheme="mesh">Plasmids</api:keyword><api:keyword scheme="mesh">Time Factors</api:keyword><api:keyword scheme="mesh">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh">Genetic Therapy</api:keyword><api:keyword scheme="mesh">Hypoxia</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Open Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>17</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>research-article</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field><api:files><api:file proprietary-id="https://www.nature.com/articles/6691318.pdf"><api:file-url>https://www.nature.com/articles/6691318.pdf</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file><api:file proprietary-id="https://europepmc.org/articles/PMC2363510?pdf=render"><api:file-url>https://europepmc.org/articles/PMC2363510?pdf=render</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2470885" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1001020476" last-modified-when="2024-03-18T00:22:54.63+00:00"><api:citation-count>16</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0731561243.29</api:identifier></api:identifiers></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01060754621.29</api:identifier></api:identifiers></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01255717430.30</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0736063251.63</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10944609</api:identifier><api:identifier scheme="pmc">PMC2363510</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>1.22</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3206 Medical Biotechnology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Biotechnology</api:keyword><api:keyword scheme="rcdc">Gene Therapy</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">5.2 Cellular and gene therapies</api:keyword><api:keyword scheme="hrcs-rac">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">5.5 Radiotherapy and other non-invasive therapies</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Cell Line</api:keyword><api:keyword scheme="mesh">Cell Separation</api:keyword><api:keyword scheme="mesh">Feasibility Studies</api:keyword><api:keyword scheme="mesh">Flow Cytometry</api:keyword><api:keyword scheme="mesh">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh">Genetic Therapy</api:keyword><api:keyword scheme="mesh">Genetic Vectors</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypoxia</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Oxygen</api:keyword><api:keyword scheme="mesh">Peptides</api:keyword><api:keyword scheme="mesh">Phosphatidylethanolamines</api:keyword><api:keyword scheme="mesh">Plasmids</api:keyword><api:keyword scheme="mesh">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh">Time Factors</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>8</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.43</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field></api:native></api:record><api:record format="native" id="242135" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000088909400019" last-modified-when="2024-03-14T05:59:28.16+00:00"><api:citation-count>23</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">C-1615-2008</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000088909400019&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1054/bjoc.2000.1318</api:text><api:links><api:link type="doi" href="http://doi.org/10.1054/bjoc.2000.1318"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1054/bjoc.2000.1318"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">347CH</api:identifier><api:identifier scheme="pubmed">10944609</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>green fluorescent protein</api:keyword><api:keyword>tumour conditions</api:keyword><api:keyword>anoxia</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field></api:native></api:record><api:record format="native" id="25311" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000088909400019" last-modified-when="2014-07-25T11:08:08.993+01:00"><api:citation-count>18</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Coralli</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hart</api:last-name><api:initials>SL</api:initials><api:first-names>SL</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>green fluorescent protein</api:keyword><api:keyword>tumour conditions</api:keyword><api:keyword>anoxia</api:keyword><api:keyword>BLADDER-CARCINOMA</api:keyword><api:keyword>SOLID TUMORS</api:keyword><api:keyword>LINE</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>PROTEINS</api:keyword><api:keyword>OXYGENATION</api:keyword><api:keyword>METASTASES</api:keyword><api:keyword>CANCERS</api:keyword><api:keyword>FLUX</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>662</api:begin-page><api:end-page>667</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Gene delivery to hypoxic cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>83</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword origin="record-data" source="eprints">green fluorescent protein</api:keyword><api:keyword origin="record-data" source="eprints">tumour conditions</api:keyword><api:keyword origin="record-data" source="eprints">anoxia</api:keyword><api:keyword origin="record-data" source="eprints">BLADDER-CARCINOMA</api:keyword><api:keyword origin="record-data" source="eprints">SOLID TUMORS</api:keyword><api:keyword origin="record-data" source="eprints">LINE</api:keyword><api:keyword origin="record-data" source="eprints">EXPRESSION</api:keyword><api:keyword origin="record-data" source="eprints">PROTEINS</api:keyword><api:keyword origin="record-data" source="eprints">OXYGENATION</api:keyword><api:keyword origin="record-data" source="eprints">METASTASES</api:keyword><api:keyword origin="record-data" source="eprints">CANCERS</api:keyword><api:keyword origin="record-data" source="eprints">FLUX</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Line</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Separation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Feasibility Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Flow Cytometry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Genetic Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Genetic Vectors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hypoxia</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Oxygen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Peptides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Phosphatidylethanolamines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Plasmids</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Time Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Line</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Oxygen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Phosphatidylethanolamines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Peptides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Flow Cytometry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Separation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Feasibility Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Genetic Vectors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Plasmids</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Time Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Genetic Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hypoxia</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3206 Medical Biotechnology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Biotechnology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Gene Therapy</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5.2 Cellular and gene therapies</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5.5 Radiotherapy and other non-invasive therapies</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Line</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Separation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Feasibility Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Flow Cytometry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Genetic Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Genetic Vectors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hypoxia</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Oxygen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Peptides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Phosphatidylethanolamines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Plasmids</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Time Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword origin="record-data" source="wos-lite">green fluorescent protein</api:keyword><api:keyword origin="record-data" source="wos-lite">tumour conditions</api:keyword><api:keyword origin="record-data" source="wos-lite">anoxia</api:keyword><api:keyword origin="record-data" source="wos">green fluorescent protein</api:keyword><api:keyword origin="record-data" source="wos">tumour conditions</api:keyword><api:keyword origin="record-data" source="wos">anoxia</api:keyword><api:keyword origin="record-data" source="wos">BLADDER-CARCINOMA</api:keyword><api:keyword origin="record-data" source="wos">SOLID TUMORS</api:keyword><api:keyword origin="record-data" source="wos">LINE</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">PROTEINS</api:keyword><api:keyword origin="record-data" source="wos">OXYGENATION</api:keyword><api:keyword origin="record-data" source="wos">METASTASES</api:keyword><api:keyword origin="record-data" source="wos">CANCERS</api:keyword><api:keyword origin="record-data" source="wos">FLUX</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-0920" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662" title="British Journal of Cancer"><api:records><api:record source-name="summary"><api:title>British Journal of Cancer</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1213/relationships"/></api:object></api:result></api:response>